Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Shanghai Junshi Biosciences (1877 HK)
Watchlist
251
Analysis
Health Care
•
China
Shanghai Junshi Biosciences Co., Ltd. operates as a biopharmaceutical company. The Company develops and sells small molecule drugs, antibody drug conjugates, and other products. Shanghai Junshi Biosciences markets its products worldwide.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Shanghai Junshi Biosciences
•
16 Jun 2025 08:30
Shanghai Junshi Bioscience (1877 HK): Placement Good, A Long Term Bet for Sure
Shanghai Junshi is raising funds through 41M H share placement to support drug development and replenishment of working capital. Lower R&D...
Tina Banerjee
Follow
245 Views
Share
bullish
•
Shanghai Junshi Biosciences
•
29 Apr 2025 21:32
Shanghai Junshi Bioscience (1877 HK): Tuoyi Gains Momentum; Losses Narrow; New Geographies Open Up
Shanghai Junshi Biosciences sees 32% revenue growth in 1Q25, driven by toripalimab in China. Loss narrowed to RMB 239M in 1Q25 from RMB 307M in...
Tina Banerjee
Follow
274 Views
Share
bullish
•
Shanghai Junshi Biosciences
•
16 Jan 2025 23:02
Shanghai Junshi Bioscience (1877 HK): Key Drug on High Trajectory; Geopolitical Tension Spoils Party
Shanghai Junshi Biosciences sees strong revenue growth for toripalimab in China. While US launch of the drug was in-line, geopolitical tensions...
Tina Banerjee
Follow
421 Views
Share
bearish
•
Shanghai Junshi Biosciences
•
13 Apr 2023 09:12
[Junshi Biosciences (1877 HK) TP Change]: Medium to near Term Outlook Is Still Cloudy at Best
We continue to view JUNSHI’s Phase III pipeline, consisting of Senaparib (JS109/IMP4297)(PARP), Ongericimab (JS002)(PCSK9), Bevacizumab...
Blue Lotus Research Institute
Follow
378 Views
Share
bullish
•
Cosco Shipping Development
•
26 May 2025 12:04
A/H Premium Tracker (To 23 May 2025): AH Premia Contract, H Premia Names Perform Best; Batteries!
AH Premia contract again. Interestingly, the best performing tranche of discount was stocks where Hs trade at a premium to As. BYD squeezed. CATL a...
Travis Lundy
Follow
600 Views
Share
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.53.10
x